BXL-628
98%
- Product Code: 107960
CAS:
199798-84-0
Molecular Weight: | 442.7 g./mol | Molecular Formula: | C₂₉H₄₃FO₂ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
BXL-628 is primarily investigated for its potential therapeutic applications in the treatment of benign prostatic hyperplasia (BPH). It functions as a selective vitamin D receptor agonist, which helps in regulating cell growth and differentiation in the prostate gland. By targeting the vitamin D pathway, it aims to reduce prostate enlargement and alleviate associated urinary symptoms. Additionally, its mechanism may offer a novel approach to managing BPH with potentially fewer side effects compared to traditional therapies. Research is ongoing to explore its efficacy and safety in clinical settings.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.001 | 10-20 days | ฿30,816.00 |
+
-
|
BXL-628
BXL-628 is primarily investigated for its potential therapeutic applications in the treatment of benign prostatic hyperplasia (BPH). It functions as a selective vitamin D receptor agonist, which helps in regulating cell growth and differentiation in the prostate gland. By targeting the vitamin D pathway, it aims to reduce prostate enlargement and alleviate associated urinary symptoms. Additionally, its mechanism may offer a novel approach to managing BPH with potentially fewer side effects compared to traditional therapies. Research is ongoing to explore its efficacy and safety in clinical settings.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :